-
1
-
-
84944800184
-
Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes
-
PID: 26378978
-
Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373(22):2117–28.
-
(2015)
N Engl J Med
, vol.373
, Issue.22
, pp. 2117-2128
-
-
Zinman, B.1
Wanner, C.2
Lachin, J.M.3
-
2
-
-
84994180780
-
Empagliflozin and progression of kidney disease in type 2 diabetes
-
PID: 27806236
-
Wanner C, Inzucchi SE, Zinman B. Empagliflozin and progression of kidney disease in type 2 diabetes. N Engl J Med. 2016;375(18):1801–2.
-
(2016)
N Engl J Med
, vol.375
, Issue.18
, pp. 1801-1802
-
-
Wanner, C.1
Inzucchi, S.E.2
Zinman, B.3
-
3
-
-
85021642011
-
SGLT2 inhibition in the diabetic kidney—from mechanisms to clinical outcome
-
PID: 28254770
-
van Bommel EJ, Muskiet MH, Tonneijck L, Kramer MH, Nieuwdorp M, van Raalte DH. SGLT2 inhibition in the diabetic kidney—from mechanisms to clinical outcome. Clin J Am Soc Nephrol. 2017;12(4):700–10.
-
(2017)
Clin J Am Soc Nephrol
, vol.12
, Issue.4
, pp. 700-710
-
-
van Bommel, E.J.1
Muskiet, M.H.2
Tonneijck, L.3
Kramer, M.H.4
Nieuwdorp, M.5
van Raalte, D.H.6
-
4
-
-
0027517659
-
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group
-
PID: 8413456
-
Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med. 1993;329(20):1456–62.
-
(1993)
N Engl J Med
, vol.329
, Issue.20
, pp. 1456-1462
-
-
Lewis, E.J.1
Hunsicker, L.G.2
Bain, R.P.3
Rohde, R.D.4
-
5
-
-
0035922441
-
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
-
PID: 11565518
-
Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345(12):861–9.
-
(2001)
N Engl J Med
, vol.345
, Issue.12
, pp. 861-869
-
-
Brenner, B.M.1
Cooper, M.E.2
de Zeeuw, D.3
-
6
-
-
0035922447
-
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
-
PID: 11565517
-
Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345(12):851–60.
-
(2001)
N Engl J Med
, vol.345
, Issue.12
, pp. 851-860
-
-
Lewis, E.J.1
Hunsicker, L.G.2
Clarke, W.R.3
-
7
-
-
85065599284
-
Standards of medical care in diabetes-2017: summary of revisions
-
ADA. Standards of medical care in diabetes-2017: summary of revisions. Diabetes Care. 2017;40(Suppl 1):S4–5.
-
(2017)
Diabetes Care
, vol.40
, pp. S4-S5
-
-
-
8
-
-
84982113684
-
2016 European guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)
-
PID: 27222591
-
Piepoli MF, Hoes AW, Agewall S, et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315–81.
-
(2016)
Eur Heart J
, vol.37
, Issue.29
, pp. 2315-2381
-
-
Piepoli, M.F.1
Hoes, A.W.2
Agewall, S.3
-
9
-
-
84891865819
-
Characterization of renal glucose reabsorption in response to dapagliflozin in healthy subjects and subjects with type 2 diabetes
-
PID: 23735727
-
DeFronzo RA, Hompesch M, Kasichayanula S, et al. Characterization of renal glucose reabsorption in response to dapagliflozin in healthy subjects and subjects with type 2 diabetes. Diabetes Care. 2013;36(10):3169–76.
-
(2013)
Diabetes Care
, vol.36
, Issue.10
, pp. 3169-3176
-
-
DeFronzo, R.A.1
Hompesch, M.2
Kasichayanula, S.3
-
10
-
-
84885171560
-
The clinical efficacy and safety of sodium glucose cotransporter-2 inhibitors in adults with type 2 diabetes mellitus
-
PID: 23744749
-
Riser Taylor S, Harris KB. The clinical efficacy and safety of sodium glucose cotransporter-2 inhibitors in adults with type 2 diabetes mellitus. Pharmacotherapy. 2013;33(9):984–99.
-
(2013)
Pharmacotherapy
, vol.33
, Issue.9
, pp. 984-999
-
-
Riser Taylor, S.1
Harris, K.B.2
-
11
-
-
84893214045
-
Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus
-
PID: 24334175
-
Cherney DZ, Perkins BA, Soleymanlou N, et al. Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus. Circulation. 2014;129(5):587–97.
-
(2014)
Circulation
, vol.129
, Issue.5
, pp. 587-597
-
-
Cherney, D.Z.1
Perkins, B.A.2
Soleymanlou, N.3
-
12
-
-
0042422126
-
Tubuloglomerular feedback and the control of glomerular filtration rate
-
PID: 12869618
-
Vallon V. Tubuloglomerular feedback and the control of glomerular filtration rate. News Physiol Sci. 2003;18:169–74.
-
(2003)
News Physiol Sci
, vol.18
, pp. 169-174
-
-
Vallon, V.1
-
13
-
-
84979582003
-
SGLT2 inhibitors and the diabetic kidney
-
PID: 27440829
-
Fioretto P, Zambon A, Rossato M, Busetto L, Vettor R. SGLT2 inhibitors and the diabetic kidney. Diabetes Care. 2016;39(Suppl 2):S165–71.
-
(2016)
Diabetes Care
, vol.39
, pp. S165-S171
-
-
Fioretto, P.1
Zambon, A.2
Rossato, M.3
Busetto, L.4
Vettor, R.5
-
14
-
-
84975840750
-
Can a shift in fuel energetics explain the beneficial cardiorenal outcomes in the EMPA-REG OUTCOME study? A unifying hypothesis
-
PID: 27289124
-
Mudaliar S, Alloju S, Henry RR. Can a shift in fuel energetics explain the beneficial cardiorenal outcomes in the EMPA-REG OUTCOME study? A unifying hypothesis. Diabetes Care. 2016;39(7):1115–22.
-
(2016)
Diabetes Care
, vol.39
, Issue.7
, pp. 1115-1122
-
-
Mudaliar, S.1
Alloju, S.2
Henry, R.R.3
-
15
-
-
0029640011
-
Hypoxia of the renal medulla—its implications for disease
-
PID: 7845430
-
Brezis M, Rosen S. Hypoxia of the renal medulla—its implications for disease. N Engl J Med. 1995;332(10):647–55.
-
(1995)
N Engl J Med
, vol.332
, Issue.10
, pp. 647-655
-
-
Brezis, M.1
Rosen, S.2
-
17
-
-
84861651942
-
Noninvasive evaluation of renal oxygenation in diabetic nephropathy by BOLD-MRI
-
PID: 21470811
-
Yin WJ, Liu F, Li XM, et al. Noninvasive evaluation of renal oxygenation in diabetic nephropathy by BOLD-MRI. Eur J Radiol. 2012;81(7):1426–31.
-
(2012)
Eur J Radiol
, vol.81
, Issue.7
, pp. 1426-1431
-
-
Yin, W.J.1
Liu, F.2
Li, X.M.3
-
18
-
-
33644999688
-
Evaluation of intra-renal oxygenation by BOLD MRI
-
PID: 16543757
-
Prasad PV. Evaluation of intra-renal oxygenation by BOLD MRI. Nephron Clin Pract. 2006;103(2):c58–65.
-
(2006)
Nephron Clin Pract
, vol.103
, Issue.2
, pp. c58-c65
-
-
Prasad, P.V.1
-
19
-
-
84899718664
-
Determinants of renal tissue oxygenation as measured with BOLD-MRI in chronic kidney disease and hypertension in humans
-
PID: 24760031
-
Pruijm M, Hofmann L, Piskunowicz M, et al. Determinants of renal tissue oxygenation as measured with BOLD-MRI in chronic kidney disease and hypertension in humans. PLoS One. 2014;9(4):e95895.
-
(2014)
PLoS One
, vol.9
, Issue.4
-
-
Pruijm, M.1
Hofmann, L.2
Piskunowicz, M.3
-
20
-
-
77951460727
-
Effect of sodium loading/depletion on renal oxygenation in young normotensive and hypertensive men
-
PID: 20308608
-
Pruijm M, Hofmann L, Maillard M, et al. Effect of sodium loading/depletion on renal oxygenation in young normotensive and hypertensive men. Hypertension. 2010;55(5):1116–22.
-
(2010)
Hypertension
, vol.55
, Issue.5
, pp. 1116-1122
-
-
Pruijm, M.1
Hofmann, L.2
Maillard, M.3
-
21
-
-
84884529387
-
Effect of dark chocolate on renal tissue oxygenation as measured by BOLD-MRI in healthy volunteers
-
PID: 23557792
-
Pruijm M, Hofmann L, Charollais-Thoenig J, et al. Effect of dark chocolate on renal tissue oxygenation as measured by BOLD-MRI in healthy volunteers. Clin Nephrol. 2013;80(3):211–7.
-
(2013)
Clin Nephrol
, vol.80
, Issue.3
, pp. 211-217
-
-
Pruijm, M.1
Hofmann, L.2
Charollais-Thoenig, J.3
-
22
-
-
84962339296
-
Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition
-
PID: 26078479
-
Peters AL, Buschur EO, Buse JB, Cohan P, Diner JC, Hirsch IB. Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition. Diabetes Care. 2015;38(9):1687–93.
-
(2015)
Diabetes Care
, vol.38
, Issue.9
, pp. 1687-1693
-
-
Peters, A.L.1
Buschur, E.O.2
Buse, J.B.3
Cohan, P.4
Diner, J.C.5
Hirsch, I.B.6
-
23
-
-
77955515855
-
Effects of the peroxisome proliferator-activated receptor (PPAR)-gamma agonist pioglitazone on renal and hormonal responses to salt in diabetic and hypertensive individuals
-
PID: 20414637
-
Zanchi A, Maillard M, Jornayvaz FR, et al. Effects of the peroxisome proliferator-activated receptor (PPAR)-gamma agonist pioglitazone on renal and hormonal responses to salt in diabetic and hypertensive individuals. Diabetologia. 2010;53(8):1568–75.
-
(2010)
Diabetologia
, vol.53
, Issue.8
, pp. 1568-1575
-
-
Zanchi, A.1
Maillard, M.2
Jornayvaz, F.R.3
-
24
-
-
1642302410
-
Effects of the peroxisomal proliferator-activated receptor-gamma agonist pioglitazone on renal and hormonal responses to salt in healthy men
-
PID: 15001599
-
Zanchi A, Chiolero A, Maillard M, Nussberger J, Brunner HR, Burnier M. Effects of the peroxisomal proliferator-activated receptor-gamma agonist pioglitazone on renal and hormonal responses to salt in healthy men. J Clin Endocrinol Metab. 2004;89(3):1140–5.
-
(2004)
J Clin Endocrinol Metab
, vol.89
, Issue.3
, pp. 1140-1145
-
-
Zanchi, A.1
Chiolero, A.2
Maillard, M.3
Nussberger, J.4
Brunner, H.R.5
Burnier, M.6
-
25
-
-
84884816112
-
Heritability, determinants and reference values of renal length: a family-based population study
-
PID: 23712436
-
Pruijm M, Ponte B, Ackermann D, et al. Heritability, determinants and reference values of renal length: a family-based population study. Eur Radiol. 2013;23(10):2899–905.
-
(2013)
Eur Radiol
, vol.23
, Issue.10
, pp. 2899-2905
-
-
Pruijm, M.1
Ponte, B.2
Ackermann, D.3
-
26
-
-
84887072459
-
Safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple rising doses of empagliflozin in patients with type 2 diabetes mellitus
-
PID: 23838841
-
Heise T, Seman L, Macha S, Jones P, Marquart A, Pinnetti S, et al. Safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple rising doses of empagliflozin in patients with type 2 diabetes mellitus. Diabetes Ther. 2013;4(2):331–45.
-
(2013)
Diabetes Ther
, vol.4
, Issue.2
, pp. 331-345
-
-
Heise, T.1
Seman, L.2
Macha, S.3
-
27
-
-
85040101855
-
Reduction of cortical oxygenation in chronic kidney disease: Evidence obtained with a new analysis method of blood oxygenation level-dependent magnetic resonance imaging
-
Milani B, Ansaloni A, Sousa-Guimaraes S, et al. Reduction of cortical oxygenation in chronic kidney disease: evidence obtained with a new analysis method of blood oxygenation level-dependent magnetic resonance imaging. Nephrol Dial Transplant. 2017;32(12):2097–105.
-
(2017)
Nephrol Dial Transplant
, vol.32
, Issue.12
, pp. 2097-2105
-
-
Milani, B.1
Ansaloni, A.2
Sousa-Guimaraes, S.3
|